Skip to content

Plasma concentrations of catecholamines following adrenaline infiltration during Cranial Osteogenesis for the Treatment of Craniosynostosis

Plasma concentrations of catecholamines following adrenaline infiltration during Cranial Osteogenesis for the Treatment of Craniosynostosis - Plasma concentrations of catecholamines following adrenaline infiltration during Cranial Osteogenesis for the Treatment of Craniosynostosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000034301
Enrollment
10
Registered
2018-09-27
Start date
2018-09-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniosynostosis

Interventions

None listed

Sponsors

Fukuoka Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children with craniosynostosis who are scheduled for cranial distraction osteogenesis surgery.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of catecholamines

Countries

Japan

Contacts

Public ContactKeiichiro Mizuno

Fukuoka Children's Hospital Department of Anesthesia

umin-ctr@dafch.org092-682-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026